Suchergebnisse - %22Myeloma%22

PubPharm (250)

51

Isatuximab in combination with anti-TGFß in RRMM : Phase 1-2 trial evaluating anti-TGFß agent (SAR439459) or pomalidomide in combination with isatuximab and dexamethasone in relapsed or refractory multiple myeloma (RRMM)

enthalten in: WHO International Clinical Trials Registry Platform | 2021

52

Isatuximab in combination with anti-TGFß in RRMM : Phase 1-2 trial evaluating anti-TGFß agent (SAR439459) or pomalidomide in combination with isatuximab and dexamethasone in relapsed or refractory multiple myeloma (RRMM)

enthalten in: WHO International Clinical Trials Registry Platform | 2021

53

Resveratrol induces AMPK and mTOR signaling inhibition-mediated autophagy and apoptosis in multiple myeloma cells

enthalten in: Acta biochimica et biophysica Sinica | 2021

von Ma, R. | Yu, D. | Peng, Y. | +9

54

High-Dose Chemotherapy With or Without Total-Body Irradiation Followed by Autologous Stem Cell Transplant in Treating Patients With Hematologic Cancer or Solid Tumors : Autologous Blood and Marrow Transplantation for Hematologic Malignancies and Selected Solid Tumors

enthalten in: ClinicalTrials.gov | 2021

55

Cereblon modulator CC-885 induces CRBN-dependent ubiquitination and degradation of CDK4 in multiple myeloma

enthalten in: Biochemical and biophysical research communications | 2021

von Zhao, M. | Hu, M. | Chen, Y. | +4

56

Isatuximab in combination with anti-TGFß in RRMM : Phase 1-2 trial evaluating anti-TGFß agent (SAR439459) or pomalidomide in combination with isatuximab and dexamethasone in relapsed or refractory multiple myeloma (RRMM)

enthalten in: WHO International Clinical Trials Registry Platform | 2021

57

Synthesis of sophocarpine triflorohydrazone and its proliferation inhibition and apoptosis induction activity in myeloma cells through Notch3-p53 signaling activation

enthalten in: Environmental toxicology | 2021

von Wang, Y. | Li, W. | Huang, F. | +4

58

Isatuximab in combination with anti-TGFß in RRMM : Phase 1-2 trial evaluating anti-TGFß agent (SAR439459) or pomalidomide in combination with isatuximab and dexamethasone in relapsed or refractory multiple myeloma (RRMM)

enthalten in: WHO International Clinical Trials Registry Platform | 2021

59

Inhibition of the Otub1/c-Maf axis by the herbal acevaltrate induces myeloma cell apoptosis

enthalten in: Cell communication and signaling : CCS | 2021

von Sun, T. | Xu, Y. | Xu, Z. | +5

60

Beclomethasone Dipropionate in Preventing Acute Graft-Versus-Host Disease in Patients Undergoing a Donor Stem Cell Transplant for Hematologic Cancer : A Phase II Study to Evaluate the Efficacy of Oral Beclomethasone Dipropionate for Prevention of Acute GVHD After Hematopoietic Cell Transplantation With Myeloablative Conditioning Regimens

enthalten in: ClinicalTrials.gov | 2021